Reuters

Reuters
Share

Reuters

 •  October 26

(Reuters) - Tesaro Inc said on Wednesday that the U.S. Food and Drug Administration approved an intravenous version of its drug to treat chemotherapy-induced nausea and vomiting in adults. The intravenous version of the already-approved drug, Varubi, will be used in combination with other agents to prevent delayed nausea and vomiting associated...

Reuters

 •  September 23

Sept 22 (Reuters) - Bristol-myers Squibb Co : * Bristol-Myers Squibb’S Opdivo (Nivolumab) receives FDA approval for the treatment of Hepatocellular Carcinoma patients previously treated with Sorafenib * ‍U.S. FDA approved Opdivo (Nivolumab) injection for intravenous use for treatment of patients with HCC previously treated with Sorafenib​ Source...

Reuters

 •  July 10

The U.S. Food and Drug Administration will ask a panel of advisors to focus on the safety of Novartis AG's experimental gene therapy drug when it meets to review the product on Wednesday. The keenly anticipated preliminary review of the leukemia treatment, posted on the FDA's website on Monday, comes two days ahead of the advisory panel meeting,...

Reuters

 •  June 7

Novartis on Wednesday touted new data from its T-cell therapy CTL019, saying it is on a par with results of experimental molecules from Kite Pharma and Juno Therapeutics that also target aggressive blood cancers. Three months after infusion, the overall response rate (ORR)among 51 adult patients with relapsed or refractory diffuse large B-cell...

Reuters

 •  February 21

Feb 21 Medicines Co * The Medicines Company announces FDA filing acceptance of new drug application for intravenous antibiotic carbavance(meropenem-vaborbactam) * Medicines Co - FDA does not currently plan to hold an advisory committee meeting to discuss application * Medicines co says tango 2 trial is ongoing and company expects results to be...

Reuters

 •  October 7, 2016

The Pfizer logo is seen at their world headquarters in New York April 28, 2014. Pfizer Inc said on Thursday it would sell its global infusion therapy business to ICU Medical Inc for $1 billion in cash and stock that will give it a major stake in the smaller company. Pfizer had acquired the hospital infusion system business, which has annual sales...

Reuters

 •  July 27, 2016

Recro Pharma Inc (REPH.O) said an intravenous version of its lead painkiller was successful in the first of two pivotal late-stage trials, sending the company's shares surging 50 percent in trading after the bell. The drug, Meloxicam, was being evaluated to treat acute pain in patients after a bunionectomy surgery, which involves removing or...

Reuters

 •  April 24, 2015

NEW YORK, April 24 (Reuters) - Private equity firms are writing bigger equity checks to finance new buyouts as leveraged lending guidelines issued by US regulators curb the amount of debt that banks are willing or able to lend.
Permira and Canada Pension Plan Investment Board (CPPIB) provided an equity check of around 50 percent to finance the $5 ...

Reuters

 •  March 25, 2015

March 25 (Reuters) - Vigmed Holding publ AB :
* Vigmed's partner launches safety I.V. catheters in India
* Says Hindustan Syringes & Medical Device Ltd. (HMD), Vigmed's manufacturing and sales partner, has launched safety I.V. catheters in India and are planning additional launches in another 20 countries Source text for Eikon: Further company ...

Reuters

 •  February 12, 2015

* Study data expected by end of Q2 - CEO
* Co seeking funding to further develop vaccine - CEO
* Vaccine has potential to hit multiple strains - CEO
* Co says can manufacture millions of doses a month (Adds CEO comment, detail)
By Natalie Grover
Feb 12 (Reuters) - Novavax Inc has begun early-stage human trials of an Ebola vaccine that it hopes can ...